IMMB — Immunotech Laboratories Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.06m
- $0.52m
Annual cashflow statement for Immunotech Laboratories, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2001 December 31st | C2002 December 31st | C2003 December 31st | 2004 December 31st | 2005 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10KSB | 10KSB/A | 10KSB/A | 10KSB/A | 10KSB |
| Standards: | — | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.754 | -1.54 | -0.615 | -0.111 | -33.6 |
| Depreciation | |||||
| Non-Cash Items | 0.153 | 0.626 | 0.015 | 0 | 33.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.472 | 0.473 | 0.541 | 0.086 | 0.145 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.11 | -0.414 | -0.057 | -0.025 | -0.284 |
| Capital Expenditures | -0.009 | -0.027 | 0 | 0 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | -0.083 | 0 | 0 | 0 |
| Change in Net Investments | |||||
| Change in Net Intangibles | |||||
| Cash from Investing Activities | -0.009 | -0.11 | 0 | 0 | 0 |
| Financing Cash Flow Items | 0.123 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.186 | 0.469 | 0.051 | 0.02 | 0.33 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.066 | -0.058 | -0.004 | -0.005 | 0.047 |